EPO announces intention to grant BMB an additional patent
The European patent office (EPO) has announced its intention to grant another patent for Biomedical Bonding AB. The patent is entitled “A composition comprising thiol, alkene and phosphonic acid containing compounds for use as a primer for adhesion improvement”."This patent further strengthens Biomedical Bonding’s Bonevolent™ patent portfolio with emphasis on novel primers and their use in bone fixation and restoration treatments. The Bonevolent™ technology is founded on resin-composites with increased biocompatibility, tissue-friendliness, and high mechanical strength” comments Evelina